Department of Cardiac Surgery, Fujian Children's Hospital (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.
BMC Pulm Med. 2024 Feb 21;24(1):92. doi: 10.1186/s12890-024-02901-5.
To evaluate the efficacy of high-flow nasal cannula oxygenation (HFNC) versus non-invasive ventilation (NIV) in pediatric patients post-congenital heart surgery (CHS) through a meta-analysis.
A comprehensive literature search was conducted across the Chinese biomedical literature database, Vip database, CNKI, Wanfang, PubMed, Embase, Cochrane Library, and Web of Science until December 20, 2022. We selected RCTs or cohort studies that met inclusion criteria for a meta-analysis using RevMan 5.4 software.
Our search yielded five publications, comprised of one randomized controlled trial and four cohort studies. Meta-analysis revealed a significant reduction in reintubation rates in children post-CHS treated with HFNC as compared to NIV [RR = 0.36, 95%CI(0.25 ~ 0.53), P < 0.00001]. There was also a notable reduction in the duration of ICU stay [MD = -4.75, 95%CI (-9.38 ~ -0.12), P = 0.04]. No statistically significant differences were observed between HFNC and NIV in terms of duration of mechanical ventilation, 24 h PaO, and PaCO post-treatment (P > 0.05). Furthermore, both groups showed no significant difference in the duration of extracorporeal circulation [MD = -8.27, 95%CI(-17.16 ~ 0.62), P = 0.07].
For pediatric patients post-CHS, HFNC appears to be more effective than NIV in reducing reintubation rates and shortening the CICU stay.
通过荟萃分析评估高流量鼻导管吸氧(HFNC)与无创通气(NIV)在先天性心脏病(CHS)后儿科患者中的疗效。
通过中文生物医学文献数据库、维普数据库、中国知网、万方、PubMed、Embase、Cochrane 图书馆和 Web of Science 对截至 2022 年 12 月 20 日的文献进行全面检索,选择符合纳入标准的 RCT 或队列研究进行荟萃分析,采用 RevMan 5.4 软件进行分析。
搜索结果共 5 篇文献,包括 1 项随机对照试验和 4 项队列研究。荟萃分析显示,HFNC 组较 NIV 组 CHS 后患儿再插管率显著降低[RR=0.36,95%CI(0.250.53),P<0.00001]。HFNC 组 ICU 住院时间也显著缩短[MD=-4.75,95%CI(-9.38-0.12),P=0.04]。HFNC 组与 NIV 组在机械通气时间、治疗后 24 h PaO 和 PaCO 方面无统计学差异(P>0.05)。此外,两组体外循环时间[MD=-8.27,95%CI(-17.16~0.62),P=0.07]无显著差异。
对于 CHS 后患儿,HFNC 似乎比 NIV 更能降低再插管率和缩短 CICU 住院时间。